Skip to main content
Equibles

NATIXIS ADVISORS, LLC

Position in ARGX — Argenx SE

CIK 1018331 Boston, MA
Back to ARGX Full portfolio

Position in ARGX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,709,273
+$2,826,778 QoQ
Shares Held
19,088
-6.3% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#95
of 507 holders
Holding Since
Sep 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NATIXIS ADVISORS, LLC holds $495,549,179 across 38 Biotechnology names. ARGX ranks #5 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 448,631 $222,848,476
2 REGN
Regeneron Pharmaceuticals, Inc.
 129,236 $80,583,815
3 TECH
BIO-TECHNE Corp
 818,905 $57,855,638
4 ALNY
Alnylam Pharmaceuticals, Inc.
 75,311 $22,670,870
5 ARGX
Argenx SE
This page 		19,088 $17,709,273
6 INSM
INSMED Inc
 73,607 $7,847,978
7 HALO
Halozyme Therapeutics, Inc.
 97,536 $7,634,142
8 JAZZ
Jazz Pharmaceuticals plc
 29,928 $7,211,749

All Filings in ARGX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,709,273 19,088
2026-03-31 $14,882,495 20,380
2025-12-31 $18,921,375 22,500
2025-09-30 $18,072,432 24,503
2025-06-30 $10,511,765 19,070
2025-03-31 $12,568,845 21,236
2024-12-31 $9,792,645 15,923
2024-09-30 $6,512,549 12,014
2024-06-30 $4,573,475 10,635
2024-03-31 $11,121,015 28,246
2023-12-31 $5,512,430 14,490
2023-09-30 $13,958,358 28,392
2022-09-30 $3,812,233 10,798